Earlier this month, “Men’s Fitness,” reviewed the unbuzzd clinical trial and described the early study findings as “promising.” Results showed that estimated blood alcoh ...

At one of the year’s premiere meetings for cancer research, melanoma vaccine data hailed by scientists sparked a share ...

There are suddenly signs of life in the initial public offering world. At least three hedge funds are gearing up for a rare biopharma IPO this week. Investors are well aware of the huge success of a ...

Detailed price information for Quantum Biopharma Ltd (QNTM-Q) from The Globe and Mail including charting and trades.

Research indicates that MS affects an estimated one million people in the United States and approximately 2.9 million people worldwide. The FDA's clearance of Quantum BioPharma's Investigational New ...

The Delhi High Court in Array Biopharma Inc. v. Deputy Controller of Patents emphasized that patent objections must be substantiated with specific claims and evidence, not merely asserted. The Court ...

In 2028, the biopharmaceutical industry will face one of the heaviest patent loss years since the patent cliff of 2012-14. Upcoming hits include blockbuster drugs from Pfizer PFE, Bristol BMY, and ...

At the same time, advances in AI are transforming how drugs are discovered, shifting the industry toward faster, more data-driven and high-throughput innovation models. That shift adds a new layer to ...

The global innovative biopharma industry has historically been led by large multinational players with headquarters in the United States, Europe and Japan. Biopharma companies based in other countries ...